![Jonathan Dole](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Jonathan Dole is the founder of Endpoint Clinical, Inc. which was founded in 2009.
He is currently working as a Director at Atreo, Inc. since 2023.
Postes actifs de Jonathan Dole
Sociétés | Poste | Début |
---|---|---|
Atreo, Inc.
![]() Atreo, Inc. Packaged SoftwareTechnology Services Atreo, Inc. offers modern testing practices for RTSM (Randomization and Trial Supply Management) that provide 10x testing coverage compared to legacy providers. The American company allows clients to preview their RTSM, tailored to their protocol, at bid defense and throughout the system design experience. Ryan Harrison has been the CEO of the company since 2021. | Directeur/Membre du Conseil | 19/07/2023 |
Anciens postes connus de Jonathan Dole
Sociétés | Poste | Fin |
---|---|---|
Endpoint Clinical, Inc.
![]() Endpoint Clinical, Inc. Information Technology ServicesTechnology Services LabCorp Endpoint Clinical, Inc. develops technology platform to support the life sciences industry. The firm have deployed systems to small, medium and large pharma for domestic and global studies. The company was founded by Jonathan Dole and Tom O’Connell in 2009 and is headquartered in San Francisco, CA. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Endpoint Clinical, Inc.
![]() Endpoint Clinical, Inc. Information Technology ServicesTechnology Services LabCorp Endpoint Clinical, Inc. develops technology platform to support the life sciences industry. The firm have deployed systems to small, medium and large pharma for domestic and global studies. The company was founded by Jonathan Dole and Tom O’Connell in 2009 and is headquartered in San Francisco, CA. | Technology Services |
Atreo, Inc.
![]() Atreo, Inc. Packaged SoftwareTechnology Services Atreo, Inc. offers modern testing practices for RTSM (Randomization and Trial Supply Management) that provide 10x testing coverage compared to legacy providers. The American company allows clients to preview their RTSM, tailored to their protocol, at bid defense and throughout the system design experience. Ryan Harrison has been the CEO of the company since 2021. | Technology Services |